Life Science Tennessee Annual Meeting

Schedule: November 11, 2010

10 a.m. Life Science Legal and Regulatory Update (CLE CREDIT) - Ryman Room

A look at the key legal and regulatory issues facing life sciences companies. More than ever, these issues are impacting the ability of new ventures to raise outside capital. Learn why many VCs are choosing not to invest in companies that haven’t already gained the necessary FDA approvals and what you can do about it.

Featured Speakers:

Mike Druckman, Hogan Lovells

Nicholas Landau, Bradley Arant Boult Cummings